Inspire Medical Systems, Inc.
INSP
$126.10
$1.561.25%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 129.91% | 138.60% | 316.59% | 181.94% | 35.13% |
| Total Depreciation and Amortization | 262.81% | 203.30% | 138.10% | 109.86% | 41.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.46% | 31.42% | 26.82% | 32.45% | 23.69% |
| Change in Net Operating Assets | -776.24% | 115.60% | 161.06% | -540.87% | 2.71% |
| Cash from Operations | -175.65% | 300.65% | 1,337.14% | -101.53% | 759.23% |
| Capital Expenditure | 28.12% | 12.52% | -14.58% | -155.26% | -211.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 187.43% | 107.51% | 30.81% | 84.75% | -- |
| Cash from Investing | 92.05% | 102.48% | 28.61% | 14.81% | -420.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 78.13% | -74.23% | 254.21% | -43.73% | -50.98% |
| Repurchase of Common Stock | -3,207.62% | -410.74% | -740.12% | -91.76% | -63.12% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -11,527.08% | -593.41% | 182.57% | -52.54% | -86.36% |
| Foreign Exchange rate Adjustments | -17.76% | -178.67% | 633.33% | -400.00% | -3,666.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -851.17% | 101.83% | 70.45% | -49.36% | -1,974.26% |